Patent ID: 7622579

Claim:
A compound of formula (I) wherein is thiomorpholin-4-yl; Y is bonded to at a substitutable atom and is independently selected from the group consisting of hydrogen; hydroxyl; R 1 ; R 1 O—; R 1 S—; CF 3 O—; R 1 S(O)—; R 1 SO 2 —; —LCOX; C 6-10 aryl; n is an integer from 0 to 4; Ar is phenyl; naphthyl; a 5-6 membered heteroaryl ring selected from the group consisting of furan, imidazole, isothiazole, isoxazole, oxadiazole, oxazole, pyran, pyrazine, pyrazole, pyridazine, pyrrole, tetrazole, thiadiazole, triazine, and triazole; or a fused 5,6 or 6,6 heteroaryl selected from the group consisting of benzimidazole, benzisoxazole, benzofiaran, benzoxazole, benzthiazole, benzothiophene, cinnoline, indazole, indole, indoline, indolizine, isobenzofiaran, isoindole, isoindoline, isoquinoline, naphthyridine, pthalazine, pteridine, pyrrolizine, quinoline, and quinolizine; R 1 is C 1-10 alkyl; L is —NH—, a direct bond, —O—, or —CH 2 —; X is H, R 1 , HO, R 1 O—, R 1 S—, —NH 2 , R 1 NH—, or (R 1 ) 2 N—; and enantiomers, diastereomers, tautomers, solvates, and pharmaceutically acceptable salts thereof.